Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 20
Filtrar
Más filtros

Banco de datos
País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Tumour Biol ; 35(9): 8415-24, 2014 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-24969557

RESUMEN

The relationship between fertility, reproductive hormones, and risk of malignant melanoma has acquired much interest in recent years. Melanocytes are hormonally responsive cells, and some in vitro studies demonstrated that estrogen hormones stimulate the growth of melanocytes. Moreover, estrogen receptors have been identified in melanoma cells, as well as in melanocytic nevi and in normal skin. Some evidences suggest a possible link between fertility treatments and the increased risk of malignant melanoma. This article addresses this association through a scrupulous search of the literature published thus far. The aim of this review is to determine the incidence of malignant melanoma in women treated with fertility drugs and to examine if the exposure to fertility treatments really increases the risk of malignant melanoma. In particular, our analysis focused on the different types of drugs and different treatment schedules used. Finally, this study provides additional insights regarding the long-term relationships between fertility drugs and the risk of malignant melanoma.


Asunto(s)
Fármacos para la Fertilidad Femenina/efectos adversos , Melanoma/epidemiología , Neoplasias Cutáneas/epidemiología , Femenino , Humanos , Incidencia , Melanoma/inducido químicamente , Medición de Riesgo , Factores de Riesgo , Neoplasias Cutáneas/inducido químicamente
2.
Dermatol Ther ; 27(2): 94-6, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-24703265

RESUMEN

A 63-year-old man showed multiple concentric erythemato-nodular lesions of approximately 1.5-3 cm in diameter, located in the parietal and temporal region. The skin biopsy allowed histological diagnosis of infundibular epidermal cyst associated with chronic granulomatous flogosis; in one of these, a well-differentiated squamous cell carcinoma arising from the cyst wall was found. The patient received isotretinoin at the daily dosage of 0.5 mg/kg/day for 5 months. During 1-year follow-up, laboratory tests, computed tomography scans, and control histology were all in the normal range, with a good improvement of the lesions. Epidermal cysts and squamous cell carcinoma are both commonly encountered in practice. However, the association of epidermal inclusion cysts and squamous cell carcinoma in the skin is very rare. In some cases, including the present one, more potent chemopreventive strategies, such as the use of systemic retinoids, must be considered. Systemic retinoids are the most heavily researched chemopreventive agents and have shown promise for multiple types of cancer, including bladder and head and neck carcinomas. We would like to recommend the possibility to administer retinoids in a squamous cell carcinoma, achieving very satisfactory results; in our case, a complete remission of malignant lesion and an improvement of epidermal cysts were made, without the development of side effects associated with retinoids.


Asunto(s)
Antineoplásicos/uso terapéutico , Carcinoma de Células Escamosas/tratamiento farmacológico , Quiste Epidérmico/tratamiento farmacológico , Neoplasias de Cabeza y Cuello/tratamiento farmacológico , Isotretinoína/uso terapéutico , Cuero Cabelludo/efectos de los fármacos , Neoplasias Cutáneas/tratamiento farmacológico , Antineoplásicos/administración & dosificación , Biopsia , Carcinoma de Células Escamosas/patología , Carcinoma de Células Escamosas/cirugía , Esquema de Medicación , Quiste Epidérmico/patología , Quiste Epidérmico/cirugía , Neoplasias de Cabeza y Cuello/patología , Neoplasias de Cabeza y Cuello/cirugía , Humanos , Isotretinoína/administración & dosificación , Masculino , Persona de Mediana Edad , Recurrencia Local de Neoplasia , Cuero Cabelludo/patología , Cuero Cabelludo/cirugía , Neoplasias Cutáneas/patología , Neoplasias Cutáneas/cirugía , Carcinoma de Células Escamosas de Cabeza y Cuello , Factores de Tiempo , Resultado del Tratamiento
3.
Drug Dev Res ; 75 Suppl 1: S81-4, 2014 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-25381987

RESUMEN

Patients affected by severe psoriasis have an increased prevalence of cardiovascular () diseases as documented by several studies. Heart rate variability (HRV) is a noninvasive method to evaluate the autonomic control of the sinus node. In this study, HRV analysis has been used to evaluate whether young patients with moderate cutaneous psoriasis have increased cardiovascular (CV) risk, in absence of CV comorbidities. Our data indicate an imbalance toward the sympathetic arm of the autonomic cardiac modulation. As the increase in sympathetic activity may be associated with a higher CV risk, moderate psoriasis could be considered to be an independent CV risk factor.


Asunto(s)
Enfermedades Cardiovasculares/epidemiología , Psoriasis/epidemiología , Adulto , Estudios de Casos y Controles , Femenino , Humanos , Italia/epidemiología , Masculino , Factores de Riesgo
4.
Cutis ; 90(3): 120-2, 2012 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-23094309

RESUMEN

Psoriasis and tuberculosis (TB) are 2 conditions with high prevalence in the general population, often present simultaneously in the same patient. The crucial cytokine involved in the pathogenesis of psoriasis, tumor necrosis factor alpha (TNF-alpha), also is important in defending against mycobacteria. Therefore, it is important to screen patients for a latent TB infection (LTBI) while they are undergoing treatment with TNF-alpha antagonists. We present a case of a patient with psoriasis and LTBI who underwent treatment with etanercept.


Asunto(s)
Tuberculosis Latente/diagnóstico , Psoriasis/tratamiento farmacológico , Factor de Necrosis Tumoral alfa/antagonistas & inhibidores , Etanercept , Humanos , Inmunoglobulina G/farmacología , Inmunoglobulina G/uso terapéutico , Factores Inmunológicos/farmacología , Factores Inmunológicos/uso terapéutico , Masculino , Tamizaje Masivo/métodos , Persona de Mediana Edad , Psoriasis/patología , Receptores del Factor de Necrosis Tumoral/uso terapéutico , Índice de Severidad de la Enfermedad , Prueba de Tuberculina , Factor de Necrosis Tumoral alfa/metabolismo
5.
Dermatol Ther ; 24(6): 581-3, 2011.
Artículo en Inglés | MEDLINE | ID: mdl-22515673

RESUMEN

Warts are among the most commonly observed dermatological diseases, caused by human papilloma virus (HPV), usually HPV1-2 subtypes; HPV4-7 are rarely found and mostly related to professional exposure (butchers and dairy workers). Different therapeutical approaches are possible, depending on extension and severity of lesions. The present authors describe the case of 32-year-old Caucasian man, who came to our attention for the presence of numerous exophytic papules on the back of both hands and over periungual regions, which appeared about 6 months before. Histological examination confirmed the clinical suspicion of common warts (HPV4). The patient underwent therapy by acitretin for 12 weeks, obtaining during the 8th week of therapy complete resolution of skin lesions. The present authors present this case for the unusual local aggressiveness of viral warts in an immunocompetent patient successfully treated with acitetrin.


Asunto(s)
Acitretina/uso terapéutico , Dermatosis de la Mano/tratamiento farmacológico , Queratolíticos/uso terapéutico , Verrugas/tratamiento farmacológico , Acitretina/administración & dosificación , Administración Oral , Adulto , Gammapapillomavirus/aislamiento & purificación , Dermatosis de la Mano/patología , Dermatosis de la Mano/virología , Humanos , Queratolíticos/administración & dosificación , Masculino , Resultado del Tratamiento , Verrugas/patología , Verrugas/virología
6.
G Ital Dermatol Venereol ; 155(1): 103-106, 2020 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-27905695

RESUMEN

Erythroplasia of Queyrat (EQ) is a rare disease involving the mucosal and transitional surfaces of the penis. Effective treatment is necessary to minimize progression to squamous cell carcinoma. The standard therapy for EQ, partial or radical penectomy, is invasive; photodynamic therapy (PDT) may be an effective, non-surgical tissue-sparing option. We report the case of a 67-year-old patient with long-standing EQ who was suc-cessfully treated with methyl aminolevulinate-PDT (MAL-PDT). A complete clinical response, confirmedby incisional biopsy, was achieved af-ter fivesessions of every-other-week treatment. The patient experienced moderate edema, erythema and pain within 5-7 days after the treatment, without urination problems. Our experience and a review of the published literature suggest that MAL-PDT may represent a valuable treatment option for selected cases of histopathologically-confirmed EQ.


Asunto(s)
Ácido Aminolevulínico/análogos & derivados , Eritroplasia/tratamiento farmacológico , Enfermedades del Pene/tratamiento farmacológico , Fotoquimioterapia/métodos , Anciano , Ácido Aminolevulínico/administración & dosificación , Eritroplasia/patología , Humanos , Masculino , Enfermedades del Pene/patología , Fármacos Fotosensibilizantes/administración & dosificación , Resultado del Tratamiento
7.
Acta Dermatovenerol Croat ; 28(2): 93-101, 2020 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-32876034

RESUMEN

Actinic keratosis (AK) is a common skin disease related to ultraviolet chronic exposure, that is now considered a squamous cell carcinoma in situ. Primary skin cancer prevention strategies should be recommended for high risk patients. There is a wide spectrum of treatment options available for AKs, and several variables should be taken into account regarding the best therapeutic choice for each patient. The purpose of this article is to review the current treatment strategies for AKs localized on the face and scalp, with a focus on the practical point of view that could be useful for choosing the best therapeutic option. The two main therapeutic approaches will be distinguished first: lesion-directed and field-directed. Afterwards, the treatment based on clinical type and patient comorbidity will be discussed.


Asunto(s)
Carcinoma in Situ/terapia , Carcinoma de Células Escamosas/terapia , Cara , Queratosis Actínica/terapia , Lesiones Precancerosas/terapia , Cuero Cabelludo , Carcinoma in Situ/patología , Carcinoma de Células Escamosas/patología , Toma de Decisiones , Humanos , Queratosis Actínica/patología , Lesiones Precancerosas/patología
8.
Acta Dermatovenerol Croat ; 27(1): 22-27, 2019 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-31032787

RESUMEN

Basal cell carcinoma (BCC) is the most frequent skin cancer and is characterized by slow growth, even if it can be locally invasive and rarely metastasizes. Many different phenotypic presentations and histopathologic subtypes have been described, and the current guidelines subdivide BCCs into low-risk (nodular and superficial) and high-risk subtypes (micronodular, infiltrating, and morphoeic BCC and those with squamous differentiation). Dermoscopy allows the identification of the features associated with these different subtypes. Compared with the low-risk forms of BCC, more aggressive ones tend to undergo more frequently incomplete surgical excision and perineural invasion, so the identification of these lesions before surgery is extremely important. The gold standard of treatment is surgery, particularly for the H region of the face and infiltrative lesions, but other options are available and selected according to many variables, including body area, age, comorbidities, and clinical, dermoscopic, and histopathological features of the lesion. Moreover, the possible complications of surgical approaches, namely healing defects, failure of skin grafts, and wound infection, should be considered. In this review we discuss the management of BCC localized on the face and scalp, according to the currently available treatment options.


Asunto(s)
Carcinoma Basocelular/diagnóstico , Carcinoma Basocelular/terapia , Neoplasias Faciales/terapia , Cuero Cabelludo , Neoplasias Cutáneas/diagnóstico , Neoplasias Cutáneas/terapia , Neoplasias Faciales/diagnóstico , Humanos
9.
J Clin Aesthet Dermatol ; 11(1): 21-25, 2018 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-29410726

RESUMEN

Background: Acne is predominantly known as a skin disorder of the adolescent population. However, current research indicates that the prevalence of adult patients with acne, especially among women, is increasing. Objective: The objective of this study was to evaluate differences between adults and teenagers with regard to acne prevalence, patient sex, acne severity, and quality of life. In adult patients, we considered differences in family history of acne, onset, and smoking habits. Design: We performed a retrospective study of a total of 1,167 patients with acne who attended our outpatient clinic from January 2008 to March 2015. Participants: The study population was divided into two groups: adolescent acne and adult acne. Among the adult subjects, 385 were female and 69 were male; among the adolescent subjects, 378 were female and 335 were male. Measurements: The severity of acne was recorded using the Global Acne Grading System. The impact of acne on quality of life was investigated using the Assessment of Quality of Life questionnaire. Results: Study results show that acne in female patients was more prevalent than in male patients. The evaluation of acne severity showed that "mild acne" is the most frequent form. With regard to smoking habits, time of onset, and family history of acne, we did not find any statistically significant differences between the sexes. Conclusion: In both sexes, there are some differences in adult acne versus the adolescent form. Treating adult acne demands a different approach to diagnosis and a tailored management plan that considers all of the variables involved.

10.
G Ital Dermatol Venereol ; 153(6): 866-871, 2018 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-29417793

RESUMEN

BACKGROUND: The aim of this study is to evaluate efficacy and tolerability of a complete skin care line consisting of an oral supplement in two distinct formulations for males and females, and a topical cream device in the treatment of mild and moderate acne. Oral supplements contain biotin, probiotic, vitamin E, zinc, nicotinamide; in the formulation for males beta sitosterol and Boswellia serrata were added, the oral supplement for females contains myo-inositol and folic acid. The topical cream device is represented by the association between active plant agents (verbascoside, Ocimum gratissimum) and keratolytic molecules (salicylic acid, gluconolactone, complex alpha-hydroxy acids). METHODS: An equal number of male and female patients with mild to moderate acne were enrolled in a double-blinded clinical trial. Efficacy and tolerability evaluations were performed at week 4 (T1) and week 12 (T2) by Global acne Grading System (GAGs). RESULTS: Most of patients had satisfactory therapeutic response, in terms of GAGs reduction. All the four groups presented a statistically significant improvement of the mean GAGs at T2 but those assuming the oral supplement improved more, as expected. CONCLUSIONS: Our data suggest that this association can be considered a new effective option for mild and moderate acne. This therapeutic line differs from others in the gender matched oral treatment.


Asunto(s)
Acné Vulgar/tratamiento farmacológico , Fármacos Dermatológicos/administración & dosificación , Suplementos Dietéticos , Queratolíticos/administración & dosificación , Acné Vulgar/patología , Administración Oral , Adolescente , Adulto , Niño , Fármacos Dermatológicos/efectos adversos , Fármacos Dermatológicos/química , Método Doble Ciego , Combinación de Medicamentos , Femenino , Humanos , Masculino , Preparaciones de Plantas/administración & dosificación , Preparaciones de Plantas/química , Ácido Salicílico/administración & dosificación , Índice de Severidad de la Enfermedad , Factores Sexuales , Resultado del Tratamiento , Adulto Joven
11.
Biomed Res Int ; 2018: 9489163, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-29808169

RESUMEN

Cutaneous squamous cell carcinoma (cSCC) is an increasing public health problem. It is a primary malignant skin tumor with Malpighian differentiation and together with basal cell carcinoma is classified among nonmelanoma skin cancers (NMSCs). cSCC usually occurs on photoexposed areas, such as the head, the neck, and the extremities, and its incidence increases with age. Invasive forms of this skin tumor tend to be more aggressive showing a higher metastatic potential, usually regarding regional lymph nodes. Treatment options for invasive cSCCs include both surgical and nonsurgical options. The therapeutic choice depends on several factors, such as anatomic location, risk factors for tumor recurrence, age, and health status of the patient. This review aims to provide an overview of the current evidence on therapeutic surgical and nonsurgical management of invasive cSCC.


Asunto(s)
Carcinoma de Células Escamosas , Neoplasias Cutáneas , Carcinoma de Células Escamosas/patología , Carcinoma de Células Escamosas/terapia , Femenino , Humanos , Masculino , Neoplasias Cutáneas/patología , Neoplasias Cutáneas/terapia
12.
World J Clin Oncol ; 8(5): 405-411, 2017 Oct 10.
Artículo en Inglés | MEDLINE | ID: mdl-29067277

RESUMEN

AIM: To determine factors independently influencing response to ingenol mebutate therapy and assess efficacy on clinical setting of non-hypertrophic non-hyperkeratotic actinic keratosis (AK). METHODS: Consecutive patients affected by non-hypertrophic non-hyperkeratotic AKs of the face or scalp were enrolled to receive ingenol mebutate 0.015% gel on a selected skin area of 25 cm2 for 3 consecutive days. Local skin reactions were calculated at each follow up visit using a validated composite score. Efficacy was evaluated by the comparison of clinical and dermoscopic pictures before the treatment and at day 57, and classified as complete, partial and poor response. RESULTS: A number of 130 patients were enrolled, of which 101 (77.7%) were treated on the face, while 29 (22.3%) on the scalp. The great majority of our study population (n = 119, 91.5%) reached at least a 75% clearance of AKs and, in particular, 58 patients (44.6%) achieved a complete response while 61 (46.9%) a partial one. Logistic backward multivariate analysis showed that facial localization, level of local skin reaction (LSR) at day 2, the highest LSR values and level of crusts at day 8 were factors independently associated with the achievement of a complete response. CONCLUSION: Ingenol mebutate 0.015% gel, when properly applied, is more effective on the face than on the scalp and efficacy is directly associated to LSR score.

13.
Acta Dermatovenerol Croat ; 24(3): 181-6, 2016 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-27663918

RESUMEN

The association between psoriasis and cardiovascular diseases has been indicated by epidemiological studies. The sub-inflammatory systemic state that characterizes both psoriasis and atherosclerosis has been proposed as the link between these conditions; it cannot, however, explain the increased incidence of sudden cardiac death reported in young patients with severe psoriasis without common cardiovascular risk factors. In a previous study, we reported higher levels of autonomic dysregulation in patients with psoriasis, concluding that the prevalence of the sympathetic arm over the parasympathetic could increase cardiovascular risk. Objective of this study was to assess the influence of etanercept on autonomic cardiovascular regulation in young patients with moderate-to-severe psoriasis without cardiovascular risk factors. Five-minute ECG recordings were collected at rest before and after 12 weeks of therapy with etanercept in 19 young patients with psoriasis without cardiovascular risk factors. The Cardiolab CE pocket PC ECG system was used for linear methods of heart rate variability (HRV) analysis. No significant change in HRV analysis parameters was apparent after 12 weeks of etanercept therapy. Our data suggest that treatment with etanercept in patients with moderate-to-severe psoriasis does not affect cardiovascular autonomic regulation and cardiovascular risk.


Asunto(s)
Antiinflamatorios no Esteroideos/uso terapéutico , Enfermedades Cardiovasculares/etiología , Etanercept/uso terapéutico , Psoriasis/tratamiento farmacológico , Psoriasis/fisiopatología , Adulto , Enfermedades Cardiovasculares/fisiopatología , Femenino , Frecuencia Cardíaca/fisiología , Humanos , Masculino , Estudios Prospectivos , Psoriasis/complicaciones , Factores de Riesgo , Adulto Joven
14.
G Ital Dermatol Venereol ; 151(1): 87-92, 2016 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-25236316

RESUMEN

INTRODUCTION: The attention to the impact of gender differences in acne is needed and, at the moment, lacking. The aim of this paper was to perform a systematic review on gender differences in acne. EVIDENCE ACQUISITION: A review of the literature was performed using the PubMed and Ovid literature search engines , using a variety of combined search terms including "acne", "gender", "sex", "females", "males". The search extended until July 2013. EVIDENCE SYNTESIS: Gender differences in acne highlight hormonal interactions as a major target for which more research is needed to translate current findings to clinically significant diagnostic and therapeutic applications. In addition, female patients are more likely to develop anxiety and depression due to their condition, and acne improvement positively influences quality of life. CONCLUSIONS: The patient's sex should not radically alter diagnostic or therapeutic efforts, although gender differences could be necessary to set up clinical management, monitoring also the psychological aspect.


Asunto(s)
Acné Vulgar/psicología , Depresión/psicología , Calidad de Vida , Ansiedad/psicología , Femenino , Humanos , Masculino , Factores de Riesgo , Factores Sexuales
15.
J Int Med Res ; 44(1 suppl): 43-47, 2016 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-27683138

RESUMEN

OBJECTIVE: To assess the influence of etanercept, an anti-tumour necrosis factor (TNF)-α agent, on autonomic cardiovascular regulation in young patients with moderate-to-severe psoriasis without cardiovascular risk factors. METHODS: Patients with psoriasis underwent 5-min electrocardiogram (ECG) recordings before and after 24 weeks of etanercept therapy. Linear heart rate variability (HRV) analysis was performed. RESULTS: The study recruited 19 patients. Frequency-domain analysis showed a significant decrease in oscillatory components attributable to sympathetic activity (LF%) and a significant decrease in low frequency/high frequency (LF/HF) ratio following etanercept therapy. CONCLUSION: Treatment with etanercept in patients with moderate-to-severe psoriasis could affect cardiovascular autonomic regulation, and subsequently reduce cardiovascular risk.

18.
Curr Pharm Des ; 20(7): 1136-8, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-23782144

RESUMEN

Skin and gut represent physical and immunological barriers between internal and external environment. Some affections involving the intestine, such as celiac disease, are reported to be associated with several different cutaneous diseases, like dermatitis herpetiforme or psoriasis. This could be better explained if gut and skin are taken as complex structures that share physio-pathological and immunological aspects. As a proof, we present the case of a woman affected by celiac disease who presented with three different skin manifestations strongly related in terms of onset, response to therapy and improvement during gluten-free diet.


Asunto(s)
Enfermedad Celíaca/complicaciones , Enfermedad Celíaca/fisiopatología , Eccema/complicaciones , Granuloma Anular/complicaciones , Psoriasis/complicaciones , Enfermedad Celíaca/genética , Eccema/fisiopatología , Femenino , Predisposición Genética a la Enfermedad/genética , Granuloma Anular/fisiopatología , Humanos , Persona de Mediana Edad , Psoriasis/genética , Psoriasis/fisiopatología
19.
Biomed Res Int ; 2013: 983902, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-23971052

RESUMEN

For a long time the relationship between inflammatory bowel diseases (IBDs) and psoriasis has been investigated by epidemiological studies. It is only starting from the 1990s that genetic and immunological aspects have been focused on. Psoriasis and IBD are strictly related inflammatory diseases. Skin and bowel represent, at the same time, barrier and connection between the inner and the outer sides of the body. The most important genetic correlations involve the chromosomal loci 6p22, 16q, 1p31, and 5q33 which map several genes involved in innate and adaptive immunity. The genetic background represents the substrate to the common immune processes involved in psoriasis and IBD. In the past, psoriasis and IBD were considered Th1-related disorders. Nowadays the role of new T cells populations has been highlighted. A key role is played by Th17 and T-regs cells as by the balance between these two cells types. New cytokines and T cells populations, as IL-17A, IL-22, and Th22 cells, could play an important pathogenetic role in psoriasis and IBD. The therapeutic overlaps further support the hypothesis of a common pathogenesis.


Asunto(s)
Citocinas/inmunología , Enfermedades Inflamatorias del Intestino/epidemiología , Enfermedades Inflamatorias del Intestino/fisiopatología , Intestinos/fisiopatología , Psoriasis/epidemiología , Psoriasis/fisiopatología , Piel/fisiopatología , Comorbilidad , Humanos , Modelos Biológicos , Prevalencia , Factores de Riesgo , Estadística como Asunto
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA